Expression of maturation-/migration-related molecules on human dendritic cells from blood and skin

Immunobiology

Volumn 198, Issue 5, 1998, Pages 568-587

  Ebner, Susanne ^a   Lenz, Angela ^a   Reider, Daniela ^a   Fritsch, Peter ^a   Schuler, Gerold ^a,b   Romani, Nikolaus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; CELL SURFACE MARKER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; UVOMORULIN;

ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; HUMAN; HUMAN CELL; LANGERHANS CELL; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0031913388     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80079-X     Document Type: Article

References (68)

1. STEINMAN, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271.
2. SCHULER, G., B. THURNER, and N. ROMANI. 1997. Dendritic cells: From ignored cells to major players in T-cell-mediated immunity. Int. Arch. Allergy Immunol. 112: 317.
3. INABA, K., M. INABA, M. DEGUCHI, K. HAGI, R. YASUMIZU, S. IKEHARA, S. MURAMATSU, and R. M. STEINMAN. 1993. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA 90: 3038.
4. CELLA, M., F. SALLUSTO, and A. LANZAVECCHIA. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9: 10.
5. ARDAVÍN, C., L. WU, C.-L. LI, and K. SHORTMAN. 1993. Thymic dendritic cells and T cells -develop simultaneously in the thymus from a common precursor population. Nature 362: 761.
6. MOLL, H. (Editor). 1995. The immune functions of epidermal Langerhans cells. R. G. Landes Company / Springer-Verlag, Austin, New York, Berlin. 1-193.
7. SCHULER, G. (Editor). 1991. Epidermal Langerhans Cells. CRC Press, Inc. Boca Raton, Florida. 1-324.
8. SALLUSTO, F., M. CELLA, C. DANIELI, and A. LANZAVECCHIA. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182: 389.
9. ROMANI, N., S. KOIDE, M. CROWLEY, M. WITMER-PACK, A. M. LIVINGSTONE, C. G. FATHMAN, K. INABA, and R. M. STEINMAN. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature epidermal Langerhans cells. J. Exp. Med. 169: 169.
10. BHARDWAJ, N., A. BENDER, N. GONZALEZ, L. K. BUI, M. C. GARRETT, and R. M. STEINMAN. 1994. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94: 797.
11. PIERRE, P., S. J. TURLEY, E. GATTI, M. HULL, J. MELTZER, A. MIRZA, K. INABA, R. M. STEINMAN, and I. MELLMAN. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388: 787.
12. ZINKERNAGEL, R. M. 1996. Immunology taught by viruses. Science 271: 173.
13. AUSTYN, J. M. 1996. New insights into the mobilization and phagocytic activity of dendritic cells. J. Exp. Med. 183: 1287.
14. KOCH, F., U. Stanzl, P. JENNEWEIN, K. JANKE, C. HEUFLER, E. KÄMPGEN, N. ROMANI, and G. SCHULER. 1996. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184: 741.
15. CELLA, M., D. SCHEIDEGGER, K. PALMER-LEHMANN, P. LANE, A. LANZAVECCHIA, and G. ALBER. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747.
16. INABA, K., S. KOIDE, and R. M. STEINMAN. 1985. Properties of memory T lymphocytes isolated from the mixed leukocyte reaction. Proc. Natl. Acad. Sci. USA 82: 7686.
17. EPSTEIN, M. M., F. DI ROSA, D. JANKOVIC, A. SHER, and P. MATZINGER. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182: 915.
18. DUBEY, C., M. CROFT, and S. L. SWAIN. 1996. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157: 3280.
19. DUBOIS, B, B. VANBERVLIET, J. FAYETTE, C. MASSACRIER, C. VAN KOOTEN, F. BRIERE, J. BANCHEREAU, and C. CAUX. 1997. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185: 941.
20. GROUARD, G., I. DURAND, L. FILGUEIRA, J. BANCHEREAU, and Y. J. LIU. 1996. Dendritic cells capable of stimulating T cells in germinal centres. Nature 384: 364.
21. CAUX, C., C. DEZUTTER-DAMBUYANT, D. SCHMITT, and J. BANCHEREAU. 1992. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360: 258.
22. RUPPERT, J., D. FRIEDRICHS, H. XU, and J. H. PETERS. 1991. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency. Immunobiology 182: 449.
23. SALLUSTO, F., and A. LANZAVECCHIA. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor -α. J. Exp. Med. 179: 1109.
24. ROMANI, N., S. GRUNER, D. BRANG, E. KÄMPGEN, A. LENZ, B. TROCKENBACHTER G. KONWALINKA, P. O. FRITSCH, R. M. STEINMAN, and G. SCHULER. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83.
25. BENDER, A., M. SAPP, G. SCHULER, R. M. STEINMAN, and N. BHARDWAJ. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196: 121.
26. ROMANI, N., D. REIDER, M. HEUER, S. EBNER, E. KÄMPGEN, B. Eibl, D. NIEDERWIESER, and G. SCHULER. 1996. Generation of mature dendritic cells from human blood - An improved method with special regard to clinical applicability. J. Immunol. Methods 196: 137.
27. + dendritic cells. Proc. Natl. Acad. Sci. USA 93: 2588.
28. HEUFLER, C., F. KOCH, and G. SCHULER. 1988. Granulocyte-macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167: 700.
29. WITMER-PACK, M. D., W. OLIVIER, J. VALINSKY, G. SCHULER, and R. M. STEINMAN. 1987. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166: 1484.
30. KOCH, F., C. HEUFLER, E. KÄMPGEN, D. SCHNEEWEISS, G. BÖCK, and G. SCHULER. 1990. Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture but in contrast to granulocyte/macrophage colony-stimulating factor without inducing their functional maturation. J. Exp. Med. 171: 159.
31. FOSTER, C. A., H. HOYOZEKI, K. RAPPENSBERGER, F. KONING, B. VOLC-PLATZER, A. RIEGER, J. E. COLIGAN, K. WOLFF, and G. STINGL. 1990. Human epidermal T cells predominantly belong to the lineage expressing a/β T cell receptor. J. Exp. Med. 171: 997.
32. KOCH, F., E. KÄMPGEN, G. SCHULER, and N. ROMANI. 1992. Effective enrichment of murine epidermal Langerhans cells by a modified - "mismatched" - panning technique. J. Invest. Dermatol. 99: 803.
33. ROMANI, N., N. BHARDWAJ, M. POPE, F. KOCH, W. J. SWIGGARD, U. O'DOHERTY, M. D. WITMER-PACK, L. HOFFMAN, G. SCHULER, K. INABA, and R. M. STEINMAN. 1997. Dendritic Cells. In Weir's Handbook of Experimental Immunology. L. A. Herzenberg, D. M. Weir, L. Herzenberg, and C. Blackwell, editors. Blackwell Science, Oxford. 156.1-156.14.
34. LENZ, A., M. HEINE, G. SCHULER, and N. ROMANI. 1993. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 92: 2587.
35. ROMANI, N., A. LENZ, H. GLASSEL, H. STÖSSEL, U. STANZL, O. MAJDIC, P. FRITSCH, and G. SCHULER. 1989. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J. Invest. Dermatol. 93: 600.
36. KÄMPGEN, E., F. KOCH, C. HEUFLER, A. EGGERT, L. L. GILL, S. GILLIS, S. K. DOWER, N. ROMANI, and G. SCHULER. 1994. Understanding the dendritic cell lineage through a study of cytokine receptors. J. Exp. Med. 179: 1767.
37. LARREGINA, A. T., A. E. MORELLI, E. KOLKOWSKI, N. SANJUAN, M. E. BARBOZA, and L. FAINBOIM. 1997. Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants. Immunology 91: 303.
38. BERG, E. L., T. YOSHINO, L. S. ROTT, M. K. ROBINSON, R. A. WARNOCK, T. K. KISHIMOTO, L. J. PICKER, and E. C. BUTCHER. 1991. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J. Exp. Med. 174: 1461.
39. STRUNK, D., C. EGGER, G. LEITNER, D. HANAU, and G. STINGL. 1997. A skin homing molecule defines the Langerhans cell progenitor in human peripheral blood. J. Exp. Med. 185: 1131.
40. KOSZIK, F., D. STRUNK, I. SIMONITSCH, L. J. PICKER, G. STINGL, and E. PAYER. 1994. Expression of monoclonal antibody HECA-452-defined E-selectin ligands on Langerhans cells in normal and diseased skin. J. Invest. Dermatol. 102: 773.
41. SYMINGTON, F. W., E. H. HOLMES, and B. E. SYMINGTON. 1992. Human epidermal keratinocyte expression of sialyl-Lewis X. J. Invest. Dermatol. 99: 601.
42. x expression on human Langerhans cells. J. Invest. Dermatol. 101: 175.
43. SRINIVAS, U., M. LARSSON, A. LUNDBLAD, and U. Forsum. 1993. E-selectin involvement in in vitro adhesion of blood dendritic cells to human umbilical cord endothelial cells. Scand. J. Immunol. 38: 273.
44. PICKL, W. F., O. MAJDIC, P. KOHL, J. STÖCKL, E. RIEDL, C. SCHEINECKER, C. BELLO-FERNANDEZ, and W. KNAPP. 1996. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol. 157: 3850
45. TANG, A., M. AMAGAI, L. G. GRANGER, J. R. STANLEY, and M. C. UDEY. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361: 82.
46. BLAUVELT, A., S. I. KATZ, and M. C. UDEY. 1995. Human Langerhans cells express E-cadherin. J. Invest. Dermatol. 104: 293.
47. UDEY, M. C. 1997. Cadherins and Langerhans cell immunobiology. Clin. Exp. Immunol. 107 Suppl. 1: 6.
48. SCHWARZENBERGER, K., and M. C. UDEY. 1996. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106: 553.
49. GEISSMANN, F., J. F. EMILE, P. ANDRY, C. THOMAS, S. FRAITAG, Y. DE PROST, and N. BROUSSE. 1997. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J. Pathol. 181: 301.
50. BORKOWSKI, T. A., B. J. VAN DYKE, K. SCHWARZENBERGER, V. W. MCFARLAND, A. G. FARR, and M. C. UDEY. 1994. Expression of E-cadherin by murine dendritic cells: E-cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells. Eur. J. Immunol. 24: 2767.
51. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFa. J. Exp. Med. 184: 695.
52. PLOW, E. F., T. HERREN, A. REDLITZ, L. A. MILES, and J. L. HOOVER-PLOW. 1995. The cell biology of the plasminogen system. FASEB J. 9: 939.
53. STAHL, A., and B. M. MUELLER. 1994. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res. 54: 3066.
54. NEWMAN, P. J. 1997. The biology of PECAM-1. J. Clin. Invest. 99: 3.
55. BROWN, K. A., P. BEDFORD, M. MACEY, D. A. MCCARTHY, F. LEROY, A. J. VORA, A. J. STAGG, D. C. DUMONDE, and S. C. KNIGHT. 1997. Human blood dendritic cells: Binding to vascular endothelium and expression of adhesion molecules. Clin. Exp. Immunol. 107: 601.
56. RAHDON, R. A., C. L. LIN, R. M. SURI, P. J. MORRIS, J. M. AUSTYN, and J. A. ROAKE. 1997 An endothelial cell-derived chemotactic factor promotes transendothelial migration of human dendritic cells. Transplant. Proc. 29: 1121.
57. PRAGER, E., R. SUNDER-PLASSMANN, C. HANSMANN, C. KOCH, W. HOLTER, W. KNAPP, and H. STOCKINGER. 1996. Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J. Exp. Med. 184: 41.
58. ZHOU, L.-J., and T. F. TEDDER. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821.
59. HOLNESS, C. L., R. P. DA SILVA, J. FAWCETT, S. GORDON, and D. L. SIMMONS. 1993. Macrosialin, a mouse macrophage restricted glycoprotein, is a member of the lamp/lgp family. J. Biol. Chem. 268: 9661.
60. PETZELBAUER, P., D. FÖDINGER, K. RAPPERSBERGER, B. VOLC-PLATZER, and K. WOLFF. 1993. CD68 positive epidermal dendritic cells. J. Invest. Dermatol. 101: 256.
61. ARDAVIJN, C. 1997. Thymic dendritic cells. Immunol. Today 18: 350.
62. PETERS, J. H., R. GIESELER, B. THIELE, and F. STEINBACH. 1996. Dendritic cells: From ontogenetic orphans to myelomonocytic descendants. Immunol. Today 17: 273.
63. SCHULER, G., and R.M. STEINMAN. 1997. Dednritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186: 1183.
64. ZITVOGEL, L., J. I. MAYORDOMO, T. TJANDRAWAN, A. B. DELEO, M. R. CLARKE, M. T. LOTZE, and W. J. STORKUS. 1996. Therapy of murine tumors with rumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183: 87.
65. BARRATT-BOYES, S. M., S. C. WATKINS, and O. J. FINN. 1997. In vivo migration of dendritic cells ifferentiated in vitro - A chimpanzee model. J. Immunol. 158: 4543.
66. Hsu, F. J., C. BENIKE, F. Fagnoni, T. M. LILES, D. CZERWINSKI, B. TAIDI, E. G. ENGELMAN, and R. LEVY. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2: 52.
67. PICKER, L. J., S. A. MICHIE, L. S. ROTT, and E. C. BUTCHER. 1990. A unique phenotype of skin-associated lymphocytes in humans: Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am. J. Pathol. 136: 1053.
68. NICOLA, N. A., K. WYCHERLEY, A. W. BOYD, J. E. LAYTON, D. GARY, amd D. METCALF. 1993. Neutralizing and nonneutralizing monoclonal antibodies to the human granulocyte-macrophage colony-stimulating factor receptor a-chain. Blood 82: 1724.